Macdonald R L
Department of Neurology, University of Michigan Medical Center, Ann Arbor.
J Neural Transm. 1988;72(3):173-83. doi: 10.1007/BF01243417.
Two actions of clinically used antiepileptic drugs have been studied using mouse neurons in primary dissociated cell culture. The antiepileptic drugs phenytoin, carbamazepine and valproic acid were demonstrated to limit sustained high frequency repetitive firing of action potentials at free serum concentrations that are achieved in patients being treated for epilepsy. Furthermore, an active metabolite of carbamazepine also limited sustained high frequency repetitive firing while inactive metabolites of phenytoin and carbamazepine did not limit sustained high frequency repetitive firing. Phenobarbital and clinically used benzodiazepines limited sustained high frequency repetitive firing of action potentials, but only at concentrations achieved during the treatment of generalized tonic-clonic status epilepticus. Ethosuximide did not limit sustained high frequency repetitive firing even at concentrations four times those achieved in the serum of patients treated for generalized absence seizures. Phenobarbital and clinically used benzodiazepines enhanced postsynaptic GABA responses at concentrations achieved free in the serum during treatment of generalized tonic-clonic or generalized absence seizures. However, phenytoin, carbamazepine, valproic acid and ethosuximide did not modify postsynaptic GABA responses at therapeutic free serum concentrations. These results suggest that the ability of antiepileptic drugs to block generalized tonic-clonic seizures and generalized tonic-clonic status epilepticus may be related to their ability to block high frequency repetitive firing of neurons. The mechanism underlying blockade of myoclonic seizures may be related to the ability of antiepileptic drugs to enhance GABAergic synaptic transmission. The mechanism underlying management of generalized absence seizures remains unclear.
利用原代解离细胞培养的小鼠神经元,对临床使用的抗癫痫药物的两种作用进行了研究。抗癫痫药物苯妥英、卡马西平和丙戊酸在癫痫患者治疗时达到的游离血清浓度下,被证明可限制动作电位的持续高频重复发放。此外,卡马西平的一种活性代谢物也能限制持续高频重复发放,而苯妥英和卡马西平的无活性代谢物则不能限制持续高频重复发放。苯巴比妥和临床使用的苯二氮䓬类药物可限制动作电位的持续高频重复发放,但仅在全身性强直阵挛性癫痫持续状态治疗期间达到的浓度下有效。乙琥胺即使在浓度为泛发性失神发作患者血清中浓度四倍时,也不能限制持续高频重复发放。苯巴比妥和临床使用的苯二氮䓬类药物在全身性强直阵挛性或泛发性失神发作治疗期间达到的血清游离浓度下,可增强突触后GABA反应。然而,苯妥英、卡马西平、丙戊酸和乙琥胺在治疗性游离血清浓度下不会改变突触后GABA反应。这些结果表明,抗癫痫药物阻断全身性强直阵挛性发作和全身性强直阵挛性癫痫持续状态的能力可能与其阻断神经元高频重复发放的能力有关。肌阵挛性发作阻断的潜在机制可能与抗癫痫药物增强GABA能突触传递的能力有关。泛发性失神发作管理的潜在机制仍不清楚。